The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases

Ghazwan Butrous

Abstract


Phosphodiesterase inhibitors (PDE) can be used as therapeutic agents for various diseases such as dementia, depression, schizophrenia and erectile dysfunction in men, as well as congestive heart failure, chronic obstructive pulmonary disease, rheumatoid arthritis, other inflammatory diseases, diabetes and various other conditions. In this review we will concentrate on one type of PDE, mainly PDE5 and its role in pulmonary vascular diseases.

Full Text:

PDF

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Ghazwan Butrous

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.